GEA Pharma Systems’ activities include partnering with customers to develop new products and enhance clinical effectiveness; the supply of R&D-scale and stand-alone production-scale equipment; and the installation of complete integrated process lines.
Penn Pharma elected to work with GEA
Pharma Systems because of its proven track record in containment technology and expertise in creating fully integrated production lines. GEA’s approach was to eliminate the use of isolation suits in favour of containment
interfaces (BUCK® MC high containment valves and Hicoflex®).
The new plant now includes the first
commercial PharmaConnect® “through the wall” system in Europe.